Meet our expert speaker – Jane Perlmutter, Ph.D., MBA: 

Jane Perlmutter is a long-term survivor of multiple cancers and a dedicated advocate whose work is shaped by her personal experiences, formal training in cognitive psychology (Ph.D.), computer and information science (MS), and business (MBA), as well as a career spanning academia, non-profit R&D, corporate leadership, and consulting. Early in her advocacy, she served as a peer counselor and board member for Y-ME, and as a grant reviewer for ACS, CDMRP, and PCORI. She has contributed to research from early translational studies to real-world data projects, with a current focus on clinical trials—ensuring the patient voice guides research priorities and protocols, and championing innovative trial designs that accelerate access to new treatments. She serves as lead advocate for the I-SPY2 and TAPUR Master Protocol trials and is a long-standing member of the Alliance for Clinical Trials in Oncology, as well as ASCO, National Academy of Medicine, and NCI committees. Beyond cancer, Jane works with numerous government and non-profit organizations, including as past chair of PCORI’s Patient Engagement Advisory Panel, a member of its Clinical Trials Advisory Committee, and a steering committee member for the Clinical Trials Transformation Initiative (CTTI). Passionate about developing future advocates and fostering collaboration with researchers, she has delivered training for many advocacy groups and served on the faculty of the ASCO/AACR Methods in Clinical Research Workshop and SITC’s SCION workshop. Her leadership has been recognized with the AACR Distinguished Public Service Award and ASCO’s Patient Advocate Award, both in 2023.